Microbicide Research, Development, and Introduction, Round 3
The summary for the Microbicide Research, Development, and Introduction, Round 3 grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Agency for International Development, which is the U.S. government agency offering this grant.
Microbicide Research, Development, and Introduction, Round 3: Description of funding opportunity included in attached document.
| Federal Grant Title: | Microbicide Research, Development, and Introduction, Round 3 |
| Federal Agency Name: | Agency for International Development |
| Grant Categories: | Other |
| Type of Opportunity: | Other |
| Funding Opportunity Number: | APS-OAA-14-000076 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 98.001 |
| CFDA Descriptions: | USAID Foreign Assistance for Programs Overseas |
| Current Application Deadline: | Jul 9, 2014 |
| Original Application Deadline: | Jul 9, 2014 |
| Posted Date: | Jun 6, 2014 |
| Creation Date: | Jun 6, 2014 |
| Archive Date: | Aug 8, 2014 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $4,000,000 |
| Minimum Federal Grant Award: | $1,000,000 |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Category Explanation
- The CAPRISA 004 clinical trial of 1% tenofovir gel, conducted by South African investigators and jointly supported by USAID and the Government of South Africa, was the first demonstration that a vaginal microbicide could significantly reduce the risk of HIV infection. This proof of concept, announced in July 2010, focused attention on the need to confirm the safety and effectiveness of this product, obtain regulatory approval from the relevant national authorities, and prepare for introduction of this new HIV prevention technology designed to help meet the needs of women in developing countries. Simultaneously, other promising microbicide leads are moving forward in the product development pipeline as well. Although research and development (R&D) for improved and alternative microbicide products will continue to be of interest, a new and broader range of activities is now needed to move the USAID program forward toward microbicide introduction. This APS is intended to support the creative research and other innovative activities that are now essential to advance potential microbicides toward regulatory approval and then to successfully introduce them into delivery programs. Attaining these objectives will fill a critical gap in the options women and girls currently have to protect themselves from HIV infection.
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Eligibility requirements included in attached document.
- Grant Announcement Contact
- Petrina Williams
Contract Specialist
Phone 202-567-5368
Agreement Specialist
Agency for International Development 202-567-4664 - Similar Government Grants
- • Accelerating ChoiCe, Equity, and Sustainability for Services
- • USAID/Ethiopia health Security Activity
- • Democracy Indicators Monitoring Survey 4 (DIMS4)
- • Libya Engagement with Voters for Equitable Representation (EVER)
- • USAID/South Sudan Care and Treatment Activity
- • Textbook and Learning Materials Program
- • Field-Support Program
- • FY-2005 Disaster Response Initiative in Northeast Sudan
- More Grants from the Agency for International Development
- • Accelerating ChoiCe, Equity, and Sustainability for Services
- • Democracy Indicators Monitoring Survey 4 (DIMS4)
- • LAC Regional Fund to Expand Inclusive Access to Quality Basic Education
- • Global Resilience Against Drug-Resistant Tuberculosis (GRAD-TB)
- • NPI Annual Program Statement (New Partnerships Initiative (NPI)/Conflict Prevention and Re...